Home/ Supplements/ Echinacea/ Echinacea 500 mg

Echinacea 500 mg

product on market Other (e.g. tea bag) herbscience Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Echinacea purpurea is researched for its potential to support the immune system and reduce the duration of common cold symptoms. However, the overall strength of clinical evidence for these effects remains limited. This ingredient profile is associated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Echinacea 500 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Caplet(s)
Serving Size
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 400.0mg (380 products) 36 studies (A:1, B:10)
Market median: 400.0mg (380 products) 36 studies (A:1, B:10)

Other Ingredients

Dicalcium Phosphate Microcrystalline Cellulose Croscarmellose Sodium Stearic Acid Silica Magnesium Stearate Pharmaceutical Glaze
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Take one caplet daily as a dietary supplement or as recommended by a healthcare professional.

Warnings & Precautions

WARNING: Pregnant or lactating women should consult with their physician prior to taking this product.

Keep out of reach of children.

Do not use if seal is broken.

Additional Information

TC# 54060602 ITEM# N4170

STANDARDIZED-FULL POTENCY

support IMMUNE FUNCTION

(BB) BLUEPRINT BOTANICALS(TM)

Protect from heat, light and moisture.

Metadata

Product Details

UPC / SKU0 35046 04170 0
DSLD Entry Date2012-03-23
Product TypeBotanical
FormOther (e.g. tea bag)
DSLD ID7102
Data Updated2026-04-11
Research

Research Evidence

38
Research Sources
52
Avg Quality
15
Meta Analysis
12
Systematic Review
6
Rct
2
Clinical Trial
1
Regulatory Source
1
Openfda Safety
A Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis
Meta Analysis Clinical nutrition ESPEN 2025 PubMed DOI
B Echinacea for preventing and treating the common cold
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis
Meta Analysis Nutrients 2024 PubMed DOI
B Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
Rct International journal of molecular sciences 2024 PubMed DOI
B Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis
Meta Analysis Academic pediatrics 2018 PubMed DOI
B Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Meta Analysis The Lancet. Infectious diseases 2007 PubMed
B Herbal Medicine for Cough: a Systematic Review and Meta-Analysis
Meta Analysis Forschende Komplementarmedizin (2006) 2015 PubMed DOI
B Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
View all evidence for Echinacea →
Compare

Similar Products

View all Echinacea products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.